Immix Biopharma Inc
IMMX
$7.98-8.06%
End of day · as of Oct 16, 2026, 9:30 PM ET
Mkt cap
$640.71M
EV/Sales
27.3
P/E ratio
N/A
FY2022 Revenue
$20.00M
EPS (H1 2026)
$-0.36
Gross Margin (FY2022)
N/A
Profit Margin (FY2022)
N/A
Beta
0.12
Div yield
N/A
Sector
Healthcare
Immix Biopharma Inc (IMMX) is a biotechnology company listed on US.
Latest reported IMMX revenue for 2022-12-08 was $20.0M. IMMX currently screens at market cap $640.7M.
Use this IMMX research hub for sector, financials, and filings — not a live tape.
Latest cached year on this hub. Full IMMX income, balance, and cash tables.
Immix Biopharma Inc (IMMX) is a biotechnology company in the Healthcare sector.
Latest cached Immix Biopharma Inc (IMMX) revenue for Dec 8, 2022 was $20.0M. Statements: https://lician.com/financials/immx
Immix Biopharma Inc (IMMX) market capitalization is $640.7M on the latest cached snapshot.
Immix Biopharma Inc (IMMX) cached previous close $8.68; day range $7.98 – $8.67; volume 1,466,253. Session quote: https://lician.com/quote/immx
Immix Biopharma Inc (IMMX) latest cached earnings event is "IMMX earnings" on Aug 14, 2026. Earnings calendar: https://lician.com/earnings
The latest cached IMMX filing is 8-K · Sep 30, 2026. Filings: https://lician.com/sec/immx